- Nod to Serum Institute of India for phase 2, 3 human clinical trials of Oxford vaccine candidate
- Nod to Serum Institute of India for phase 2, 3 human clinical trials of Oxford vaccine candidate
- New Delhi: The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed COVID-19 vaccine candidate in the country.
|
- News by the Day
|
 |